LianBio (LIANY)
USD 0.26
(-0.04%)
USD 0.26
(-0.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 258.93 Million | -99.06 Million | -164.17 Million | -98.31 Million | -11.72 Million |
| Net Income | 311.13 Million | -110.15 Million | -196.56 Million | -139.84 Million | -24.37 Million |
| Depreciation & Amortization | 1.32 Million | 1 Million | 525.69 Thousand | 76.13 Thousand | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | 19.14 Million | 8.66 Million | 5.17 Million | - |
| Change in working capital | -23.32 Million | 7.98 Million | 13.8 Million | 171.29 Thousand | 3.12 Million |
| Other non-cash items | 7.97 Million | 7.21 Million | 6.58 Million | 57.3 Million | 9.53 Million |
| Investing Cash Flow | 99.3 Million | -69.11 Million | -156.14 Million | -887.52 Thousand | - |
| Investments in PPE | -374.67 Thousand | -1.84 Million | -948.25 Thousand | -887.52 Thousand | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -148.49 Million | -302.77 Million | -155.19 Million | - | - |
| Sales/Maturities of investments | 248.17 Million | 235.49 Million | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | 1.78 Million | 1.7 Million | 313.68 Million | 310.28 Million | 55.09 Million |
| Debt repayment | - | - | - | -14.98 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 1.78 Million | 1.7 Million | 313.68 Million | 295.29 Million | 55.09 Million |
| Other Financing Activities | - | - | -6.35 Million | -15.24 Million | - |
| Accounts receivables | -38.1 Million | -1.39 Million | 14.23 Million | -20.03 Million | - |
| Accounts payables | 2.58 Million | -1.7 Million | -1.71 Million | 4.17 Million | - |
| Inventory | - | - | - | - | - |
| Other working capital | 12.2 Million | 11.08 Million | 1.27 Million | 16.03 Million | 3.12 Million |
| Cash at beginning of period | 79.22 Million | 228.17 Million | 254.35 Million | 43.29 Million | -74.72 Thousand |
| Cash at end of period | 438.58 Million | 79.22 Million | 228.17 Million | 254.35 Million | 43.29 Million |
| Capital Expenditure | -374.67 Thousand | -1.84 Million | -948.25 Thousand | -887.52 Thousand | - |
| Effect of forex changes on cash | - | -2.21 Million | 449 Thousand | 325 Thousand | - |
| Net cash flow / Change in cash | 359.36 Million | -148.95 Million | -26.17 Million | 211.05 Million | 43.37 Million |
| Free Cash Flow | 258.56 Million | -100.9 Million | -165.11 Million | -99.19 Million | -11.72 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 311.13 Million | 383.73 Million | -24.04 Million | -21.38 Million | -23.99 Million | -110.15 Million |
| Depreciation & Amortization | 1.32 Million | 347.37 Thousand | 300.01 Thousand | 296.78 Thousand | 323.36 Thousand | 1 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 4.54 Million | 4.49 Million | 4.27 Million | 19.14 Million |
| Change in working capital | -23.32 Million | -30.46 Million | 4.24 Million | -160.72 Thousand | 3.05 Million | 7.98 Million |
| Other non-cash items | 7.97 Million | -87.48 Thousand | -340.34 Thousand | 6.22 Million | -1.05 Million | 7.21 Million |
| Investing Cash Flow | 99.3 Million | 21.6 Million | 15.57 Million | 21.67 Million | 40.46 Million | -69.11 Million |
| Investments in PPE | -374.67 Thousand | -146.66 Thousand | -159.43 Thousand | -49.61 Thousand | -18.96 Thousand | -1.84 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -148.49 Million | -20.92 Million | -40.29 Million | -41.53 Million | -45.73 Million | -302.77 Million |
| Sales/Maturities of investments | 248.17 Million | 42.67 Million | 56.02 Million | 63.25 Million | 86.22 Million | 235.49 Million |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.78 Million | 1.78 Million | - | - | - | 1.7 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.78 Million | 1.78 Million | - | - | - | 1.7 Million |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -38.1 Million | -38.96 Million | 115.82 Thousand | -15.05 Thousand | 755.52 Thousand | -1.39 Million |
| Accounts payables | 2.58 Million | -2.34 Million | 4.45 Million | -3.49 Million | 3.96 Million | -1.7 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 12.2 Million | 10.84 Million | -320.61 Thousand | 3.34 Million | -1.67 Million | 11.08 Million |
| Cash at beginning of period | 79.22 Million | 103.45 Million | 104.05 Million | 102.33 Million | 79.22 Million | 228.17 Million |
| Cash at end of period | 438.58 Million | 438.58 Million | 103.45 Million | 104.05 Million | 102.33 Million | 79.22 Million |
| Capital Expenditure | -374.67 Thousand | -146.66 Thousand | -159.43 Thousand | -49.61 Thousand | -18.96 Thousand | -1.84 Million |
| Effect of forex changes on cash | - | - | -266 Thousand | -933 Thousand | 201 Thousand | -2.21 Million |
| Net cash flow / Change in cash | 359.36 Million | 335.12 Million | -599.04 Thousand | 1.72 Million | 23.11 Million | -148.95 Million |
| Free Cash Flow | 258.56 Million | 311.37 Million | -16.02 Million | -19.17 Million | -17.61 Million | -100.9 Million |
3563
CSX
LI
QLIFE
MTSUY
RBCN